Archer-Daniels-Midland

NYSE: ADM · Real-Time Price · USD
48.32
-1.84 (-3.67%)
At close: May 21, 2025, 3:59 PM

Archer-Daniels-Midland Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Ag Services and Oilseeds Revenue 66.52B 77.46B 83.69B 70.45B 55.67B 54.63B 11.42B
Ag Services and Oilseeds Revenue Growth -14.13% -7.44% +18.78% +26.57% +1.89% +378.36% n/a
Carbohydrate Solutions Revenue 11.23B 14.54B 16.34B 12.67B 9.42B 11.15B 3.83B
Carbohydrate Solutions Revenue Growth -22.73% -11.00% +28.91% +34.48% -15.52% +190.85% n/a
Nutrition Revenue 7.35B 7.47B 7.84B 6.93B 5.96B 5.79B n/a
Nutrition Revenue Growth -1.57% -4.72% +13.02% +16.35% +2.99% n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 932M 943M 905M 907M 951M 908M 815M 841M 881M 897M 818M 814M 829M 786M 720M 739M 749M 749M 636M 638M 664M 654M 578M 602M 659M 558M 534M 560M 513M 463M 478M 531M 521M 470M 561M 520M 475M 482M 511M 519M 498M
Selling, General, and Administrative Revenue Growth -1.17% +4.20% -0.22% -4.63% +4.74% +11.41% -3.09% -4.54% -1.78% +9.66% +0.49% -1.81% +5.47% +9.17% -2.57% -1.34% 0.00% +17.77% -0.31% -3.92% +1.53% +13.15% -3.99% -8.65% +18.10% +4.49% -4.64% +9.16% +10.80% -3.14% -9.98% +1.92% +10.85% -16.22% +7.88% +9.47% -1.45% -5.68% -1.54% +4.22% n/a
Research and Development Revenue n/a n/a n/a n/a n/a 256M n/a n/a n/a 216M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a